TTR and cardiac amyloidosis: There is growing clinical awareness regarding transthyretin (TTR)‐related cardiac amyloidosis (CA), partly driven by the surfacing of specific disease‐modifying treatments both for variant (TTRv) and for wild‐type (TTRwt) TTR‐CA.1, 2